Home   >  
GPCR/G Protein
Adenylate Cyclase

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Adenylate Cyclase

Chemical Structure Cat. No. Product Name CAS No.
Fipexide hydrochloride Chemical Structure
BCP48920 Fipexide hydrochloride 34161-23-4
Fipexide hydrochloride is a biochemical which may act as a cognition activator.
Lypressin Chemical Structure
BCP25055 Lypressin 50-57-7
Lysipressin, Induces contraction of the rabbit urinary bladder smooth muscle, activate adenylate-cyclase. Lysipressin is Antidiuretic hormone that have been found in pigs and some marsupial families.
LRE1 Chemical Structure
BCP47054 LRE1 1252362-53-0
LRE1 is a novel specific and allosteric inhibitor of soluble adenylyl cyclase (sAC), binding to the bicarbonate activator binding site and inhibiting sAC via a unique allosteric mechanism, preventing sAC-dependent processes in cellular and physiological systems.
TDI-10229 Chemical Structure
BCP44963 TDI-10229 TDI-10229
TDI-10229 is a potent and orally bioavailable inhibitor of soluble adenylyl cyclase (sAC, ADCY10).
KH 7 Chemical Structure
BCP40647 KH 7 330676-02-3
KH7 is a novel Inhibitor of Soluble Adenylyl Cyclase (Sac).
2',5'-Dideoxyadenosine Chemical Structure
BCP34863 2',5'-Dideoxyadenosine 6698-26-6
2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site with an IC50 of 3 µM . 2',5'-Dideoxyadenosine is a nucleoside analog and exerts a potent antiadrenergic action in heart.
CB-7921220 Chemical Structure
BCP34644 CB-7921220 115453-99-1
CB-7921220 is an adenylate cyclase inhibitor.
ST034307 Chemical Structure
BCP34643 ST034307 133406-29-8
ST034307 is a potent and selective adenylyl cyclase 1 (AC1) inhibitor, with IC50 of 2.3 μM.
SQ 22536 Chemical Structure
BCP28072 SQ 22536 17318-31-9
SQ22536 is an effective adenylate cyclase (AC) inhibitor.
Forskolin Chemical Structure
BCP07063 Forskolin 66575-29-9
Forskolin is a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory and adenylate cyclase activating properties. The activation of adenylate cyclase results in increased intracellular cyclic AMP in most tissue and cells.